-
1
-
-
37349003172
-
Morbilidad y mortalidad en pacientes con tratamiento anticoagulante oral
-
Navarro JL, Cesar JM, Fernández MA, Fontcuberta J, Reverter JC, Gol-Freixas J. Morbilidad y mortalidad en pacientes con tratamiento anticoagulante oral. Rev Esp Cardiol. 2007;60:1226-32.
-
(2007)
Rev Esp Cardiol
, vol.60
, pp. 1226-1232
-
-
Navarro, J.L.1
Cesar, J.M.2
Fernández, M.A.3
Fontcuberta, J.4
Reverter, J.C.5
Gol-Freixas, J.6
-
2
-
-
0000568298
-
An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier
-
MacFarlane RG. An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier. Nature. 1994;202:98-9.
-
(1994)
Nature
, vol.202
, pp. 98-99
-
-
MacFarlane, R.G.1
-
3
-
-
0002002620
-
Coagulation cascade: An overview
-
Loscalzo J, Schafer AI, editores, Boston: Blackwell Scientific;
-
Schafer AI. Coagulation cascade: an overview. En: Loscalzo J, Schafer AI, editores. Thrombosis and hemorrhage. Boston: Blackwell Scientific; 1994. p. 3-12.
-
(1994)
Thrombosis and hemorrhage
, pp. 3-12
-
-
Schafer, A.I.1
-
4
-
-
0028151281
-
Platelet coagulation complex assembly in a tissue-factor initiated system
-
Monroe DM, Roberts HR. Hoffman M. Platelet coagulation complex assembly in a tissue-factor initiated system. Br J Haemat. 1994;88:364-71.
-
(1994)
Br J Haemat
, vol.88
, pp. 364-371
-
-
Monroe, D.M.1
Roberts, H.R.2
Hoffman, M.3
-
5
-
-
34548151808
-
-
for the Task Force of the European Society of Cardiology
-
Caterina RD, Husted S, Wallentin L, Agnelli G, Bachmann F, Baigent C, et al; for the Task Force of the European Society of Cardiology. Eur Heart J. 2007;28:880-913.
-
(2007)
Eur Heart J
, vol.28
, pp. 880-913
-
-
Caterina, R.D.1
Husted, S.2
Wallentin, L.3
Agnelli, G.4
Bachmann, F.5
Baigent, C.6
-
6
-
-
0041694480
-
Ximegalatran compared with warfarin for prevention of thromboembolism in patients with non-valvular atrial fibrillation: Rationales, objectives and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V)
-
Halperin JL. Ximegalatran compared with warfarin for prevention of thromboembolism in patients with non-valvular atrial fibrillation: rationales, objectives and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V). Am Heart J. 2003;146:431-8.
-
(2003)
Am Heart J
, vol.146
, pp. 431-438
-
-
Halperin, J.L.1
-
7
-
-
0021104088
-
Trial of combined warfarin plus dipyridamole or aspirin in prosthetic heart valve replacement: Danger of aspirin compared to dipyridamole
-
Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, et al. Trial of combined warfarin plus dipyridamole or aspirin in prosthetic heart valve replacement: danger of aspirin compared to dipyridamole. Am J Cardiol. 1983;51:1537-41.
-
(1983)
Am J Cardiol
, vol.51
, pp. 1537-1541
-
-
Chesebro, J.H.1
Fuster, V.2
Elveback, L.R.3
McGoon, D.C.4
Pluth, J.R.5
Puga, F.J.6
-
8
-
-
5644295138
-
Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation. A randomized study
-
Pérez-Gómez F, Alegría E, Berjón J, Iriarte JA, Sumadle J, Salvador A, et al. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation. A randomized study. J Am Coll Cardiol. 2004;44:1557-66.
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 1557-1566
-
-
Pérez-Gómez, F.1
Alegría, E.2
Berjón, J.3
Iriarte, J.A.4
Sumadle, J.5
Salvador, A.6
-
9
-
-
33645511293
-
Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: A sub-analysis of NASPEAF randomised trial
-
Pérez-Gómez F, Salvador A, Zumalde J, Iriarte JA, Berjón J, Alegría E, et al. Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomised trial. Eur Heart J. 2006;27:960-7.
-
(2006)
Eur Heart J
, vol.27
, pp. 960-967
-
-
Pérez-Gómez, F.1
Salvador, A.2
Zumalde, J.3
Iriarte, J.A.4
Berjón, J.5
Alegría, E.6
-
10
-
-
34548311921
-
Antithrombotic therapy in elderly patients with atrial fibrillation: Effects and bleeding complication: a stratified analysis of the NASPEAF randomized trial
-
Pérez-Gómez F, Iriarte JA, Zumalde J, Berjón J, Salvador A, Alegría E, et al. Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complication: a stratified analysis of the NASPEAF randomized trial. Eur Heart J. 2007;228:996-1003.
-
(2007)
Eur Heart J
, vol.228
, pp. 996-1003
-
-
Pérez-Gómez, F.1
Iriarte, J.A.2
Zumalde, J.3
Berjón, J.4
Salvador, A.5
Alegría, E.6
-
11
-
-
33846701898
-
Seguridad de la asociación de aspirina, clopidogrel y acenocumarol en pacientes con indicación de anticoagulación
-
Sánchez-Torrijos J, Gudin-Uriel M, Ridocci-Soriano F. Seguridad de la asociación de aspirina, clopidogrel y acenocumarol en pacientes con indicación de anticoagulación. Rev Esp Cardiol. 2006;59:1345-6.
-
(2006)
Rev Esp Cardiol
, vol.59
, pp. 1345-1346
-
-
Sánchez-Torrijos, J.1
Gudin-Uriel, M.2
Ridocci-Soriano, F.3
-
12
-
-
0347287009
-
Uso de anticoagulantes orales en pacientes con fibrilación auricular dados de alta en el año 2000
-
Blanch P, Freixa R, Ibernón M, Delso J, Salas E, Sobrepera JL, et al. Uso de anticoagulantes orales en pacientes con fibrilación auricular dados de alta en el año 2000. Rev Esp Cardiol. 2003;56:1057-63.
-
(2003)
Rev Esp Cardiol
, vol.56
, pp. 1057-1063
-
-
Blanch, P.1
Freixa, R.2
Ibernón, M.3
Delso, J.4
Salas, E.5
Sobrepera, J.L.6
-
13
-
-
85081143555
-
Italian Federation of Anticoagulation Clinics. A guide to oral anticoagulation treatment recommendations of the Italian Federation of Anticoagulation Clinics
-
Italian Federation of Anticoagulation Clinics. A guide to oral anticoagulation treatment recommendations of the Italian Federation of Anticoagulation Clinics. Haematologica J Hematol. 2003;88 Suppl 2:1-52.
-
(2003)
Haematologica J Hematol
, vol.88
, Issue.SUPPL. 2
, pp. 1-52
-
-
-
14
-
-
33748473159
-
Anticoagulación en la fibrilación auricular no valvular: ¿son efectivas y seguras las recomendaciones científicas en la práctica clínica diaria?
-
Ruiz-Ortiz M, Romo-Peñas E, Franco-Zapata M, Mesa-Rubio D, Anguita-Sánchez M, Delgado-Ortega M, et al. Anticoagulación en la fibrilación auricular no valvular: ¿son efectivas y seguras las recomendaciones científicas en la práctica clínica diaria? Rev Esp Cardiol. 2006;59:688-95.
-
(2006)
Rev Esp Cardiol
, vol.59
, pp. 688-695
-
-
Ruiz-Ortiz, M.1
Romo-Peñas, E.2
Franco-Zapata, M.3
Mesa-Rubio, D.4
Anguita-Sánchez, M.5
Delgado-Ortega, M.6
-
15
-
-
37349092541
-
-
Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC: Guía de práctica clínica 2006 para el manejo de pacientes con fibrilación auricular. Versión resumida. Rev Esp Cardiol. 2006;59:1329.e1-64.
-
Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC: Guía de práctica clínica 2006 para el manejo de pacientes con fibrilación auricular. Versión resumida. Rev Esp Cardiol. 2006;59:1329.e1-64.
-
-
-
-
16
-
-
33644650849
-
Optimal INR for prevention of stroke and death in atrial fibrillation: A critical appraisal
-
Odén A, Fahlén, Hart R. Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. Thromb Res. 2006;117:493-9.
-
(2006)
Thromb Res
, vol.117
, pp. 493-499
-
-
Odén, A.1
Fahlén2
Hart, R.3
|